Literature DB >> 8014029

Increased interleukin 2 transcription in murine lymphocytes by ciprofloxacin.

K Riesbeck1, A Forsgren.   

Abstract

The fluoroquinolone antibiotic, ciprofloxacin (cipro), induces hyperproduction of interleukin 2 (IL-2) and interferon-gamma (IFN-gamma) in stimulated human peripheral blood lymphocytes. In this investigation an enhanced and prolonged IL-2 and IL-2 mRNA response was also detected in both stimulated (T cell mitogens or alloantigens) murine splenocytes and in the stimulated murine T cell line EL-4 in the presence of ciprofloxacin (5-80 micrograms/ml) as compared to control cells without antibiotics. However, in contrast to human lymphocytes, IFN-gamma production was inhibited and IFN-gamma mRNA levels were unaffected at 24 h and only slightly upregulated at 48 and 72 h of culture in murine splenocytes incubated with cipro (20 micrograms/ml). EL-4 cells were transfected with a plasmid containing the IL-2 promoter and enhancer region linked to the chloramphenicol acetyltransferase (CAT) reporter gene. Analysis of CAT activity revealed that cipro enhanced IL-2 gene induction. In addition, EL-4 cells incubated with ciprofloxacin showed an early peak and more activated nuclear factor of activated T cells (NFAT-1) as compared to control cells without antibiotics. Cipro did not affect the nuclear transcription factors AP-1 or NFIL-2A. Taken together, cipro inhibited IFN-gamma synthesis, but enhanced IL-2 production in murine lymphocytes by means of influencing NFAT-1 and causing an increased IL-2 transcription.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8014029     DOI: 10.1016/0162-3109(94)90050-7

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  9 in total

1.  Effect of ciprofloxacin-induced prostaglandin E2 on interleukin-18-treated monocytes.

Authors:  Hideo Kohka Takahashi; Hiromi Iwagaki; Dong Xue; Goutarou Katsuno; Sachi Sugita; Kenji Mizuno; Shuji Mori; Shinya Saito; Tadashi Yoshino; Noriaki Tanaka; Masahiro Nishibori
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

2.  Immunomodulatory and protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide.

Authors:  Itamar Shalit; Limor Horev-Azaria; Ina Fabian; Hannah Blau; Naam Kariv; Itsak Shechtman; Hannah Alteraz; Yehudith Kletter
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

3.  Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.

Authors:  K Riesbeck; A Forsgren; A Henriksson; A Bredberg
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

4.  Effect of moxifloxacin on production of proinflammatory cytokines from human peripheral blood mononuclear cells.

Authors:  Jung-Hyun Choi; Min-Jin Song; Seung-Han Kim; Su-Mi Choi; Dong-Gun Lee; Jin-Hong Yoo; Wan-Shik Shin
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

5.  CP-115,953 stimulates cytokine production by lymphocytes.

Authors:  K Riesbeck; A Forsgren
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

6.  Effects of fluoroquinolones on the migration of human phagocytes through Chlamydia pneumoniae-infected and tumor necrosis factor alpha-stimulated endothelial cells.

Authors:  Silvia M Uriarte; Robert E Molestina; Richard D Miller; Jorge Bernabo; Alicia Farinati; Kumiko Eiguchi; Julio A Ramirez; James T Summersgill
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

7.  Effect of trovafloxacin on production of cytokines by human monocytes.

Authors:  A A Khan; T R Slifer; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

8.  Determination of fluorinated quinolone antibacterials by ion chromatography with fluorescence detection.

Authors:  Yan-zhen Zhang; Zheng-yi Zhang; Yan-chun Zhou; Li Liu; Yan Zhu
Journal:  J Zhejiang Univ Sci B       Date:  2007-05       Impact factor: 3.066

9.  Prophylactic ciprofloxacin treatment prevented high mortality, and modified systemic and intestinal immune function in tumour-bearing rats receiving dose-intensive CPT-11 chemotherapy.

Authors:  H Xue; C J Field; M B Sawyer; L A Dieleman; V E Baracos
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.